VBL Wins $2.5M Grant to Progress Pivotal-Stage Anticancer Gene Therapy – Genetic Engineering & Biotechnology News
|
VBL Wins $2.5M Grant to Progress Pivotal-Stage Anticancer Gene Therapy
Genetic Engineering & Biotechnology News VBL Therapeutics won an ILS8.75 (approximately $2.5 million) grant from the Israel Innovation Authority to support continued clinical development of the firm's lead Phase III-stage gene therapy ofranergene obadenovec (VB-111). The anti-angiogenic … |
